Ameriprise
EVFM

Ameriprise’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Ameriprise’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-709
Closed -$477K – 3953
2014
Q4 		$477K Buy
+709
New +$536K ﹤0.01% 3139

Other funds holding EVFM

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Ameriprise's EVFM Position: Q1 2015 in Review

Ameriprise sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2015, closing a stake of 709 shares — an estimated $477K sold.

Ameriprise first reported a position in EVFM in Q4 2014 and held it in 1 quarter. The position peaked at $477K in Q4 2014. 21 funds tracked by Wall St. Rank hold EVFM as of Q1 2015.

  • Ameriprise reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Ameriprise sold 709 Evofem Biosciences, Inc. Common Stock shares in Q1 2015, an estimated $477K.
  • Ameriprise first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • Ameriprise's Evofem Biosciences, Inc. Common Stock position peaked at $477K in Q4 2014.
  • 21 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2015.

Based on Ameriprise's 13F filing for Q1 2015, filed 14 May 2015.